A Multicenter, Prospective, Open-lable Study to Evaluate the Efficacy and Safety of Deferasirox in Chinese Thalassaemia Major (TM) Patients.
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2015
At a glance
- Drugs Deferasirox (Primary)
- Indications Thalassaemia
- Focus Adverse reactions; Therapeutic Use
- 01 Dec 2015 New trial record